3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide

C108H112FN27O9 — CID 160889201

IUPAC3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide
SMILESCN1CCN(c2cc(F)cc(C(=O)Nc3cn[nH]c3-c3nc4ccc(CN5CCOCC5)cc4[nH]3)c2)CC1.COc1ccc(C)cc1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.O=C(Nc1cn[nH]c1-c1cc2cc(CN3CCOCC3)ccc2[nH]1)c1ncccc1NCc1ccccc1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cccc(-c2ccccc2)c1
InChIInChI=1S/C29H29N7O2.C28H26N6O2.C27H31FN8O2.C24H26N6O3/c37-29(28-24(7-4-10-30-28)31-17-20-5-2-1-3-6-20)34-26-18-32-35-27(26)25-16-22-15-21(8-9-23(22)33-25)19-36-11-13-38-14-12-36;35-28(22-8-4-7-21(16-22)20-5-2-1-3-6-20)32-25-17-29-33-26(25)27-30-23-10-9-19(15-24(23)31-27)18-34-11-13-36-14-12-34;1-34-4-6-36(7-5-34)21-14-19(13-20(28)15-21)27(37)32-24-16-29-33-25(24)26-30-22-3-2-18(12-23(22)31-26)17-35-8-10-38-11-9-35;1-15-3-6-21(32-2)17(11-15)24(31)28-20-13-25-29-22(20)23-26-18-5-4-16(12-19(18)27-23)14-30-7-9-33-10-8-30/h1-10,15-16,18,31,33H,11-14,17,19H2,(H,32,35)(H,34,37);1-10,15-17H,11-14,18H2,(H,29,33)(H,30,31)(H,32,35);2-3,12-16H,4-11,17H2,1H3,(H,29,33)(H,30,31)(H,32,37);3-6,11-13H,7-10,14H2,1-2H3,(H,25,29)(H,26,27)(H,28,31)
InChIKeySOAQRNLULVOPRX-UHFFFAOYSA-N
MW1951.26 g/mol
LogP15.64
Rot. Bonds26

About 3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide

3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide (PubChem CID 160889201) has the molecular formula C108H112FN27O9 and a molecular weight of 1951.26 g/mol. Its IUPAC name is 3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide.

Molecular Properties

Compound Name3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide
PubChem CID160889201
Molecular FormulaC108H112FN27O9
Molecular Weight1951.26 g/mol
Exact Mass1949.91
IUPAC Name3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide
SMILESCN1CCN(c2cc(F)cc(C(=O)Nc3cn[nH]c3-c3nc4ccc(CN5CCOCC5)cc4[nH]3)c2)CC1.COc1ccc(C)cc1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.O=C(Nc1cn[nH]c1-c1cc2cc(CN3CCOCC3)ccc2[nH]1)c1ncccc1NCc1ccccc1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cccc(-c2ccccc2)c1
InChIInChI=1S/C29H29N7O2.C28H26N6O2.C27H31FN8O2.C24H26N6O3/c37-29(28-24(7-4-10-30-28)31-17-20-5-2-1-3-6-20)34-26-18-32-35-27(26)25-16-22-15-21(8-9-23(22)33-25)19-36-11-13-38-14-12-36;35-28(22-8-4-7-21(16-22)20-5-2-1-3-6-20)32-25-17-29-33-26(25)27-30-23-10-9-19(15-24(23)31-27)18-34-11-13-36-14-12-34;1-34-4-6-36(7-5-34)21-14-19(13-20(28)15-21)27(37)32-24-16-29-33-25(24)26-30-22-3-2-18(12-23(22)31-26)17-35-8-10-38-11-9-35;1-15-3-6-21(32-2)17(11-15)24(31)28-20-13-25-29-22(20)23-26-18-5-4-16(12-19(18)27-23)14-30-7-9-33-10-8-30/h1-10,15-16,18,31,33H,11-14,17,19H2,(H,32,35)(H,34,37);1-10,15-17H,11-14,18H2,(H,29,33)(H,30,31)(H,32,35);2-3,12-16H,4-11,17H2,1H3,(H,29,33)(H,30,31)(H,32,37);3-6,11-13H,7-10,14H2,1-2H3,(H,25,29)(H,26,27)(H,28,31)
InChIKeySOAQRNLULVOPRX-UHFFFAOYSA-N
XLogP15.64
TPSA423.46 Ų
H-Bond Donors13
H-Bond Acceptors24
Rotatable Bonds26
Heavy Atoms145
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001951.26
LogP ≤ 515.64
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1024

Analyze 3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[2-[2-tert-butyl-5-[3-[2-(2-tert-butylphenoxy)ethyl-methylcarbamoyl]-5-fluoro-1H-indazol-6-yl]phenoxy]ethyl]-7-[3-tert-butyl-4-[2-[methyl(2H-pyrazolo[3,4-b]pyridine-3-carbonyl)amino]ethoxy]phenyl]-N-methylimidazo[1,2-b]pyridazine-2-carboxamide
CID 123580115
N-[2-[2-tert-butyl-5-[3-[2-(2-tert-butylphenoxy)ethyl-methylcarbamoyl]-5-fluoro-1H-indazol-6-yl]phenoxy]ethyl]-7-[3-tert-butyl-4-[2-[(3-ethyl-1H-1,2,4-triazonine-9-carbonyl)-methylamino]ethoxy]phenyl]-N-methylimidazo[1,2-b]pyridazine-2-carboxamide
CID 123930675
N-[5-[4-fluoro-7-[4-[2-[4-fluoro-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-pyrazolo[3,4-c]pyridin-3-yl]-1H-benzimidazol-4-yl]furan-2-yl]-3-[4-(furan-3-yl)-1H-benzimidazol-2-yl]-1H-pyrazolo[5,4-c]pyridin-5-yl]-3-pyridinyl]benzamide
CID 145032836
N-[5-[7-fluoro-8-[4-[2-[6-fluoro-1-methyl-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]indazol-3-yl]-3,4-dihydroimidazo[4,5-b]azepin-8-yl]furan-2-yl]-4-[7-(furan-3-yl)-3H-imidazo[4,5-b]pyridin-2-yl]-1,2-dihydrocinnolin-6-yl]-3-pyridinyl]benzamide
CID 145037079
2-[4-[4-[5-[4-[3-[4-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethylamino]-2-oxoethyl]piperazin-1-yl]phenyl]-5-(2-fluoro-6-methoxyphenyl)pyrazolo[4,3-d]pyrimidin-1-yl]-2-fluoro-6-methoxyphenyl]-1H-pyrazolo[4,3-d]pyrimidin-3-yl]phenyl]piperazin-1-yl]-N-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propyl]acetamide
CID 155281213
2-(2,6-dioxopiperidin-3-yl)-4-[2-[3-[4-[4-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-3-yl]phenyl]piperazin-1-yl]-3-oxopropoxy]ethylamino]isoindole-1,3-dione
CID 155281350
2-(2,6-dioxopiperidin-3-yl)-4-[2-[2-[2-[2-[2-[3-[4-[4-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-3-yl]phenyl]piperazin-1-yl]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethylamino]isoindole-1,3-dione
CID 155281353
2-(2,6-dioxopiperidin-3-yl)-4-[2-[2-[2-[2-[3-[4-[4-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-3-yl]phenyl]piperazin-1-yl]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethylamino]isoindole-1,3-dione
CID 155281354
5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-(2-methylpyrimidin-5-yl)-1H-indazole-3-carboxamide;5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-N-[6-[(methyl-methylidene-oxo-lambda6-sulfanyl)amino]-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-(2-methylpyrimidin-5-yl)-1H-indazole-3-carboxamide;N-(2-methylpyrimidin-5-yl)-5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(2-methylpyrimidin-5-yl)-5-(5-phenoxy-3-pyridinyl)-1H-indazole-3-carboxamide
CID 157076556
5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-N-(2-methylpyrimidin-5-yl)-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-(5-phenoxy-3-pyridinyl)-N-pyridin-4-yl-1H-indazole-3-carboxamide
CID 157102765
5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-N-[6-(dimethylamino)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-(5-phenoxy-3-pyridinyl)-1H-indazole-3-carboxamide
CID 157110041
1-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-3-[(4-fluorophenyl)methyl]urea;2-fluoro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-(trifluoromethyl)benzamide;2-methoxy-4-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-phenyl-1,3-oxazole-4-carboxamide
CID 157158634

Frequently Asked Questions

What is the IUPAC name of 3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide?
The IUPAC name of 3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide (CID 160889201) is 3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide.
What is the SMILES notation for 3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide?
The canonical SMILES for 3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide is CN1CCN(c2cc(F)cc(C(=O)Nc3cn[nH]c3-c3nc4ccc(CN5CCOCC5)cc4[nH]3)c2)CC1.COc1ccc(C)cc1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.O=C(Nc1cn[nH]c1-c1cc2cc(CN3CCOCC3)ccc2[nH]1)c1ncccc1NCc1ccccc1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cccc(-c2ccccc2)c1.
What is the InChIKey of 3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide?
The InChIKey is SOAQRNLULVOPRX-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H29N7O2.C28H26N6O2.C27H31FN8O2.C24H26N6O3/c37-29(28-24(7-4-10-30-28)31-17-20-5-2-1-3-6-20)34-26-18-32-35-27(26)25-16-22-15-21(8-9-23(22)33-25)19-36-11-13-38-14-12-36;35-28(22-8-4-7-21(16-22)20-5-2-1-3-6-20)32-25-17-29-33-26(25)27-30-23-10-9-19(15-24(23)31-27)18-34-11-13-36-14-12-34;1-34-4-6-36(7-5-34)21-14-19(13-20(28)15-21)27(37)32-24-16-29-33-25(24)26-30-22-3-2-18(12-23(22)31-26)17-35-8-10-38-11-9-35;1-15-3-6-21(32-2)17(11-15)24(31)28-20-13-25-29-22(20)23-26-18-5-4-16(12-19(18)27-23)14-30-7-9-33-10-8-30/h1-10,15-16,18,31,33H,11-14,17,19H2,(H,32,35)(H,34,37);1-10,15-17H,11-14,18H2,(H,29,33)(H,30,31)(H,32,35);2-3,12-16H,4-11,17H2,1H3,(H,29,33)(H,30,31)(H,32,37);3-6,11-13H,7-10,14H2,1-2H3,(H,25,29)(H,26,27)(H,28,31).
What are the key properties of 3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide?
3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide has a molecular weight of 1951.26 g/mol, XLogP of 15.64, 26 rotatable bonds, 13 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(benzylamino)-N-[5-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;3-fluoro-5-(4-methylpiperazin-1-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-5-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide is sourced from PubChem (CID 160889201), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).